Posted by Michael Wonder on 09 Feb 2023
CoolHealth enters US market with TargetCool, a breakthrough FDA class II medical device offering unprecedented precise, rapid cooling for pain management and bruise minimisation
8 February 2023 - CoolHealth is entering the US market with a breakthrough FDA Class II medical device, TargetCool.
Leveraging groundbreaking, tuneable cooling technology, TargetCool rapidly cools the skin allowing providers to specifically set a "target" skin temperature down to the exact degree and second– a first in medical cooling.
